Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Management of clinically inapparent adrenal mass. — J. Lau (2002) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Management of clinically inapparent adrenal mass.
Shared by
John P A Ioannidis
Stanford University
Management of clinically inapparent adrenal mass.
Article
2002
en
Authors
+5 more
JL
J. Lau
EB
Ethan M. Balk
MR
Michael B. Rothberg
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
1981
Unilateral Testicular Enlargement Resulting from Inapparent 21-Hybroxylase Deficiency
George Chrousos
,
D. Lynn Loriaux
,
Richard J. Sherins
,
Gordon B. Cutler
Article
2005
Clinically isolated syndromes suggestive of multiple sclerosis, part 2: non-conventional MRI, recovery processes, and management
David Miller
,
Frederik Barkhof
,
Xavier Montalbán
,
Alan J. Thompson
,
Massimo Filippi
Article
2002
Future Directions in the Study and Management of Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
Deborah P. Merke
,
Stefan R. Bornstein
,
Nilo A. Avila
,
George Chrousos
Article
1985
110 CURRENT MANAGEMENT OF CONGENITAL ADRENAL HYPERPLASIA (CAH): A SURVEY OF THE LAWS0N WILKINS PEDIATRIC ENDOCRINE SOCIETY (LWPES)
Penelope Feuillan
,
Gordon B. Cutler
,
D. Lynn Loriaux
,
George Chrousos
Article
2014
Adrenal insufficiency
Evangelia Charmandari
,
Nicolas C. Nicolaides
,
George Chrousos
Discussion(0)
No comments yet. Be the first to comment.